Table 2 The systems assessment of chemotherapy plus the interval EGFR TKIs versus control group.

From: Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients

control group

 

Heterogeneity

HR/RR (95% CI)

Begg’s test

Egger’s test

P value

I2

Z

P

t

P

Chemotherapy

OS

0.389

0.0

0.82 (0.69–0.98)

1.02

0.308

0.69

0.561

PFS

0.638

0.0

0.55 (0.47–0.64)

−0.24

1.000

0.60

0.589

ORR

0.033

70.6

2.36 (1.41–3.97)

0.00

1.000

0.38

0.717

DCR

0.351

0.0

1.04 (0.95–1.14)

0.75

0.452

2.02

0.113

EGFR TKIs

OS

0.135

46.1

0.87 (0.70–1.08)

0.34

0.734

0.96

0.436

PFS

0.234

31.1

0.75 (0.62–0.91)

0.00

1.000

−0.29

0.821

ORR

0.309

16.5

1.49 (1.12–2.00)

0.34

0.734

0.60

0.609

DCR

0.352

8.3

1.33 (1.15–1.54)

1.02

0.308

3.52

0.072

Back to article page